Acadia Pharmaceuticals Inc

VANGUARD GROUP INC ACAD

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

15,153,957

Value ($000)

404,762

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	404,762	0.0%	15,153,957	12/31/2025
2025 Q3	11/7/2025	323,928	0.0%	15,179,371	9/30/2025
2025 Q2	8/11/2025	329,250	0.0%	15,264,240	6/30/2025
2025 Q1	5/9/2025	252,526	0.0%	15,203,234	3/31/2025
2024 Q4	2/11/2025	255,939	0.0%	13,947,640	12/31/2024
2024 Q3	11/13/2024	212,908	0.0%	13,843,196	9/30/2024
2024 Q2	8/13/2024	222,822	0.0%	13,712,131	6/30/2024
2024 Q1	5/10/2024	245,890	0.0%	13,298,541	3/31/2024
2023 Q4	3/11/2024	419,429	0.0%	13,396,009	12/31/2023
2023 Q3	12/18/2023	283,773	0.0%	13,616,740	9/30/2023
2023 Q2	8/14/2023	331,824	0.0%	13,854,846	6/30/2023
2023 Q1	7/14/2023	257,435	0.0%	13,678,809	3/31/2023
2022 Q4	2/10/2023	211,414	0.0%	13,279,775	12/31/2022
2022 Q3	11/14/2022	211,463	0.0%	12,925,641	9/30/2022
2022 Q2	8/12/2022	174,724	0.0%	12,400,593	6/30/2022
2022 Q1	5/13/2022	304,707	0.0%	12,580,814	3/31/2022
2021 Q4	2/14/2022	287,441	0.0%	12,315,366	12/31/2021
2021 Q3	11/12/2021	201,468	0.0%	12,129,266	9/30/2021
2021 Q2	8/13/2021	280,932	0.0%	11,518,317	6/30/2021
2021 Q1	5/14/2021	280,218	0.0%	10,861,175	3/31/2021
2020 Q4	2/12/2021	566,984	0.0%	10,605,773	12/31/2020
2020 Q3	11/16/2020	427,750	0.0%	10,369,690	9/30/2020
2020 Q2	8/14/2020	516,759	0.0%	10,661,419	6/30/2020
2020 Q1	5/15/2020	464,033	0.0%	10,983,037	3/31/2020
2019 Q4	2/14/2020	454,179	0.0%	10,616,613	12/31/2019
2014 Q2	8/11/2014	109,102	0.0%	4,829,652	6/30/2014
2014 Q1	5/13/2014	116,538	0.0%	4,789,894	3/31/2014
2013 Q4	2/12/2014	107,847	0.0%	4,315,613	12/31/2013